A detailed history of Union Savings Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Union Savings Bank holds 10,247 shares of BMY stock, worth $568,196. This represents 0.26% of its overall portfolio holdings.

Number of Shares
10,247
Previous 10,467 2.1%
Holding current value
$568,196
Previous $435 Million 22.0%
% of portfolio
0.26%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$39.66 - $51.75 $8,725 - $11,385
-220 Reduced 2.1%
10,247 $530 Million
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $109,399 - $144,026
-2,718 Reduced 20.61%
10,467 $435 Million
Q1 2024

Apr 29, 2024

BUY
$47.98 - $54.4 $7,196 - $8,160
150 Added 1.15%
13,185 $715 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $8,096 - $9,660
167 Added 1.3%
13,035 $669 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $819,820 - $910,282
12,868 New
12,868 $800 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $118B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Union Savings Bank Portfolio

Follow Union Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Union Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Union Savings Bank with notifications on news.